Pediatric-specific antimicrobial susceptibility data and empiric antibiotic selection.

dc.contributor.author

Boggan, JC

dc.contributor.author

Navar-Boggan, AM

dc.contributor.author

Jhaveri, R

dc.coverage.spatial

United States

dc.date.accessioned

2017-05-27T17:16:38Z

dc.date.available

2017-05-27T17:16:38Z

dc.date.issued

2012-09

dc.description.abstract

OBJECTIVE: Duke University Health System (DUHS) generates annual antibiograms combining adult and pediatric data. We hypothesized significant susceptibility differences exist for pediatric isolates and that distributing these results would alter antibiotic choices. METHODS: Susceptibility rates for Escherichia coli isolates from patients aged ≤12 years between July 2009 and September 2010 were compared with the 2009 DUHS antibiogram. Pediatric attending and resident physicians answered case-based vignettes about children aged 3 months and 12 years with urinary tract infections. Each vignette contained 3 identical scenarios with no antibiogram, the 2009 DUHS antibiogram, and a pediatric-specific antibiogram provided. Effective antibiotics exhibited >80% in vitro susceptibility. Frequency of antibiotic selection was analyzed by using descriptive statistics. RESULTS: Three hundred seventy-five pediatric isolates were identified. Pediatric isolates were more resistant to ampicillin and trimethoprim-sulfamethoxazole (TMP-SMX) and less resistant to amoxicillin-clavulanate and ciprofloxacin (P < .0005 for all). Seventy-five resident and attending physicians completed surveys. In infant vignettes, physicians selected amoxicillin-clavulanate (P < .05) and nitrofurantoin (P < .01) more often and TMP-SMX (P < .01) less often with pediatric-specific data. Effective antibiotic choices increased from 68.6% to 82.2% (P = .06) to 92.5% (P < .01) across scenarios. In adolescent vignettes, providers reduced TMP-SMX use from 66.2% to 42.6% to 19.0% (P < .01 for both). Effective antibiotic choices increased from 32.4% to 57.4% to 79.4% (P < .01 and P = .01). CONCLUSIONS: Pediatric E. coli isolates differ significantly in antimicrobial susceptibility at our institution, particularly to frequently administered oral antibiotics. Knowledge of pediatric-specific data altered empirical antibiotic choices in case vignettes. Care of pediatric patients could be improved with use of a pediatric-specific antibiogram.

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/22891227

dc.identifier

peds.2012-0563

dc.identifier.eissn

1098-4275

dc.identifier.uri

https://hdl.handle.net/10161/14592

dc.language

eng

dc.publisher

American Academy of Pediatrics (AAP)

dc.relation.ispartof

Pediatrics

dc.relation.isversionof

10.1542/peds.2012-0563

dc.subject

Adult

dc.subject

Anti-Bacterial Agents

dc.subject

Child

dc.subject

Child, Preschool

dc.subject

Drug Resistance, Bacterial

dc.subject

Escherichia coli

dc.subject

Escherichia coli Infections

dc.subject

Female

dc.subject

Humans

dc.subject

Infant

dc.subject

Male

dc.subject

Microbial Sensitivity Tests

dc.subject

Urinary Tract Infections

dc.title

Pediatric-specific antimicrobial susceptibility data and empiric antibiotic selection.

dc.type

Journal article

duke.contributor.orcid

Boggan, JC|0000-0003-3564-2807

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/22891227

pubs.begin-page

e615

pubs.end-page

e622

pubs.issue

3

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, Cardiology

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

School of Medicine

pubs.publication-status

Published

pubs.volume

130

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Ecoli paper post-referee.docm
Size:
48.35 KB
Format:
Unknown data format